Fortrea Holdings Inc. (FTRE): Total Assets
$2.72B
As of 2025-12-31
$2.71B
As of 2026-06-30
-14.1%
3-year compound annual growth
| Period ended | Total Assets | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.72B | -24.1% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $3.58B | -17.4% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $4.33B | +1.0% | 2025-03-03, Balance as of period end |
| 2022-12-31 | $4.29B | n/a | 2024-03-13, Balance as of period end |
Total Assets at similar companies
| Company | Year ended | Total Assets | Change YoY |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | 2025-12-31 | $2.72B | -24.1% |
| Natera, Inc. (NTRA) | 2025-12-31 | $2.40B | +44.4% |
| RadNet, Inc. (RDNT) | 2025-12-31 | $3.76B | +14.4% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $2.01B | +35.5% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $1.13B | +227.5% |
| Quest Diagnostics Inc (DGX) | 2025-12-31 | $16.23B | +0.4% |
| Labcorp Holdings Inc. (LH) | 2025-12-31 | $18.39B | +0.1% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $1.41B | +8.2% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $413.23M | -15.8% |
Compare FTRE, NTRA, RDNT, GH side by side · Screen every company in Services-Medical Laboratories ↗